Gefitinib-sensitizing mutations in esophageal carcinoma

N Engl J Med. 2006 May 18;354(20):2193-4. doi: 10.1056/NEJMc052698.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics*
  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • DNA, Neoplasm / analysis
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics*
  • Esophageal Diseases / genetics
  • Esophageal Diseases / pathology
  • Esophageal Neoplasms / drug therapy
  • Esophageal Neoplasms / genetics*
  • Gefitinib
  • Humans
  • Mutation*
  • Neoplasms, Squamous Cell / drug therapy
  • Neoplasms, Squamous Cell / genetics*
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / therapeutic use*
  • RNA, Messenger / analysis

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Protein Kinase Inhibitors
  • Quinazolines
  • RNA, Messenger
  • ErbB Receptors
  • Gefitinib